Effect of nF and mF fibroblasts on the phenotype of colonocytes. by Pascale Plaisancié (13531638)

Proliferation and differentiation of myoblasts derived from satellite cells in WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Image_1_Hsa_circ_0000479 as a Novel Diagnostic Biomarker of Systemic Lupus Erythematosus.TIF by Gangqiang Guo (3278922)

“…Candidate circRNAs identified were first validated by quantitative reverse-transcription (qRT)-PCR in PBMC samples from a training-phase cohort of five SLE patients and five HCs. …”

Image_2_Hsa_circ_0000479 as a Novel Diagnostic Biomarker of Systemic Lupus Erythematosus.TIF by Gangqiang Guo (3278922)

“…Candidate circRNAs identified were first validated by quantitative reverse-transcription (qRT)-PCR in PBMC samples from a training-phase cohort of five SLE patients and five HCs. …”

The 3-D QSAR/CoMFA color contour maps for COX I (A) and COX II (B). by Pan Wang (198097)

Fiber types and muscle force in the soleus of 18-20-week-old WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Geometry and conductances of the blow fly model. by Roman V. Frolov (9647905)

Parameters of K⁺ conductances used in the models. by Roman V. Frolov (9647905)

Geometry and conductances of the cockroach model. by Roman V. Frolov (9647905)

<i>Smp_248100</i> is specifically required for vitellaria maturation following pairing with a male worm. by Jipeng Wang (419413)

“…<p>(A) qPCR showing decreased <i>Smp_248100</i> transcript levels in <i>Smp_248100(RNAi)</i> versus <i>control(RNAi)</i>. …”

Supplementary Material for: Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage by Kolkhof P. (7545230)

“…Treatment with finerenone and the low-dose combination significantly decreased systolic blood pressure after 5 weeks. There was a dose-dependent protection from cardiac and kidney fibrosis and vasculopathy with both agents, while low-dose combination therapy was more efficient than the respective monotherapy dosages on most cardiorenal histology parameters. …”

Minimum data file to support primary outcome. by Greg Carney (372057)

“…In the early intervention group probability of prescribing nitrofurantoin increased from 28% in 2010 to 38% in 2011, a difference of 9.9% (95% confidence interval [CI], 9.1% to 10.7. Ciprofloxacin decreased by 6.2% (95% CI: 5.6% to 6.9%) and TMP-SMX by 3.7% (95% CI: 3.1% to 4.2%). …”

Physician characteristics. by Greg Carney (372057)

“…In the early intervention group probability of prescribing nitrofurantoin increased from 28% in 2010 to 38% in 2011, a difference of 9.9% (95% confidence interval [CI], 9.1% to 10.7. Ciprofloxacin decreased by 6.2% (95% CI: 5.6% to 6.9%) and TMP-SMX by 3.7% (95% CI: 3.1% to 4.2%). …”

Study physician flow diagram. by Greg Carney (372057)

“…In the early intervention group probability of prescribing nitrofurantoin increased from 28% in 2010 to 38% in 2011, a difference of 9.9% (95% confidence interval [CI], 9.1% to 10.7. Ciprofloxacin decreased by 6.2% (95% CI: 5.6% to 6.9%) and TMP-SMX by 3.7% (95% CI: 3.1% to 4.2%). …”

Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

“…Collectively, statins significantly reduced IL-6 (<i>MD = -0.24</i> ng/dL <i>[95% CI, -0.36 to -0.13], I</i>^<i>2</i> <i>= 98.3%, p < 0.001</i>), TNF-α (<i>MD = -0.74</i> ng/dL <i>[95% CI, -1.08 to -0.40], I</i>^<i>2</i> <i>= 98.8%, p < 0.001</i>); and CRP (<i>MD = -1.58</i> mg/L <i>[95% CI, -2.22 to -0.94], I</i>^<i>2</i> <i>= 86.5%, p < 0.001</i>). Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. …”

Physician reflective survey results. by Greg Carney (372057)

“…In the early intervention group probability of prescribing nitrofurantoin increased from 28% in 2010 to 38% in 2011, a difference of 9.9% (95% confidence interval [CI], 9.1% to 10.7. Ciprofloxacin decreased by 6.2% (95% CI: 5.6% to 6.9%) and TMP-SMX by 3.7% (95% CI: 3.1% to 4.2%). …”

Newcastle-Ottawa scale. by Solima Sabeel (9545738)

“…Collectively, statins significantly reduced IL-6 (<i>MD = -0.24</i> ng/dL <i>[95% CI, -0.36 to -0.13], I</i>^<i>2</i> <i>= 98.3%, p < 0.001</i>), TNF-α (<i>MD = -0.74</i> ng/dL <i>[95% CI, -1.08 to -0.40], I</i>^<i>2</i> <i>= 98.8%, p < 0.001</i>); and CRP (<i>MD = -1.58</i> mg/L <i>[95% CI, -2.22 to -0.94], I</i>^<i>2</i> <i>= 86.5%, p < 0.001</i>). Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. …”

Behavior effects after LABP acute exposure. by Kassia Martins Fernandes Pereira (12219197)

“…Asterisks indicate statistical differences between groups (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). n = 24/group a-20 min; 28/group b-20 min; 28/group c-25 min; 50/group d-60 min.…”

DDX5 and DDX17 are required for KSHV lytic reactivation in BCBL1 cells and primary infection in endothelial cells. by Praneet Kaur Sandhu (21156149)

Participation of canonical and non-canonical receptors in the inhibitory action of the extracts on oxLDL internalization. by Bruno Musetti (9527085)